A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

J&J’s COVID-19 Vaccine Raises Risk of Guillain–Barré Syndrome


While the risk remains very low, an investigation into federal vaccine data found that individuals who had received the Johnson & Johnson (J&J) one-shot COVID-19 vaccination had a three times to five times higher risk of developing Guillain–Barré syndrome than those who had not received the immunization. As a result, the United States Food and Drug Administration is expected to issue a warning regarding this risk shortly.  A rare disorder affecting the immune system, Guillain–Barré syndrome attacks the nerves, leading to weakened muscles and possibly paralysis. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy